MLTX logo

MoonLake Immunotherapeutics (MLTX) EV/EBITDA

EV/EBITDA:

-1.16+0.08(+6.45%)
October 17, 2025

Summary

  • As of today, MLTX EV/EBITDA is -1.16, with a rise of +0.08 (+6.45%) during the most recent trading session on October 17, 2025.
  • Over the past year, MLTX EV/EBITDA has increased by +22.27 (+95.05%).
  • MLTX EV/EBITDA is now -383.33% below its all-time high of -0.24.

Performance

MLTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherMLTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

MLTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day+6.5%-6.7%-2.8%
1M1 Month+92.1%-92.1%-82.2%
3M3 Months+92.5%-92.6%-83.2%
6M6 Months+90.3%-88.7%-76.2%
YTDYTD+94.5%-92.3%-83.2%
1Y1 Year+95.0%-91.0%-81.0%
5Y5 Years---

MLTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month-0.24-383.3%-18.08+93.6%
3M3-Month-0.24-383.3%-18.08+93.6%
6M6-Month-0.24-383.3%-18.08+93.6%
1Y1-Year-0.24-383.3%-28.21+95.9%
3Y3-Year-0.24-383.3%-61.99+98.1%
5Y5-Year-0.24-383.3%-1492+99.9%
All-TimeAll-Time-0.24-383.3%-1492+99.9%

MLTX EV/EBITDA History

DateValue
2025
-1.16(+94.5%)
2024
-20.96(+63.9%)
2023
-58.11(-1019.7%)
DateValue
2022
-5.19(-121.8%)
2021
-2.34(+99.8%)
2020
-1333.00

FAQ

  • What is MoonLake Immunotherapeutics EV/EBITDA?
  • What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
  • What is MLTX EV/EBITDA year-to-date change?
  • What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

What is MoonLake Immunotherapeutics EV/EBITDA?

The current EV/EBITDA of MLTX is -1.16

What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24

What is MLTX EV/EBITDA year-to-date change?

MoonLake Immunotherapeutics EV/EBITDA has changed by +19.80 (+94.47%) since the beginning of the year

What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

Over the past year, MLTX EV/EBITDA has changed by +22.27 (+95.05%)
On this page